Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Pfizer’s Experimental Arthritis Pill Delayed By 3 Months
Bloomberg
Tuesday, August 21, 2012 - 11:56am
tags:
Pfizer, FDA, tofacitinib, rheumatoid arthritis
Myriad Wins Patent Ruling Again
Yahoo/Zacks
Tuesday, August 21, 2012 - 11:40am
tags:
Myriad Genetics, patents, breast cancer, ovarian cancer, Bracanalysis
Stem Cell Therapy Outlook Starting To Match Clinical Results
Seeking Alpha
Tuesday, August 21, 2012 - 11:38am
tags:
Aastrom Biosciences, Baxter International, NeoStem, Osiris, Pluristem, AMR-101
3 High-Growth Biotech Stocks With Encouraging Inventory Trends
Seeking Alpha
Tuesday, August 21, 2012 - 11:33am
tags:
Biomarin, China Biologic, Anika
ImmunoCellular CEO Steps Down But Leaves Company Well Positioned
Seeking Alpha
Tuesday, August 21, 2012 - 11:32am
tags:
ImmunoCellular Therapeutics, Dendreon, Jazz Pharmaceuticals, Merck, Verastem, Roche, Oncothyreon
The Potential Market For Arena's Belviq
Seeking Alpha
Tuesday, August 21, 2012 - 11:30am
tags:
Arena Pharmaceuticals, Belviq, obesity
Novo Nordisk CFO Explains Winning Diabetes Strategy
Investors.com
Tuesday, August 21, 2012 - 11:11am
tags:
diabetes, Novo Nordisk
Synthes Investor Suits Over J&J Takeover Dismissed
Bloomberg
Tuesday, August 21, 2012 - 11:11am
tags:
JNJ, Synthes, M&A
Johnson & Johnson: The Doom And Gloom Crowd Is Wrong
Seeking Alpha
Monday, August 20, 2012 - 12:18pm
tags:
JNJ
Now That Vivus Was Downgraded, Where Should Investors Turn?
Seeking Alpha
Monday, August 20, 2012 - 11:45am
tags:
Vivus, investors, obesity, Qsymia
6 Biotech Stocks That Could Be In For A Short Squeeze
Seeking Alpha
Monday, August 20, 2012 - 11:38am
tags:
Aveo Pharmaceutical, BioTime, ChemoCentryx, Optimer Pharmaceuticals, Clovis Oncology, PDL Biopharma
FDA calendar crowded with blockbuster decisions for Ironwood, Pfizer and Sanofi
Fierce Biotech
Monday, August 20, 2012 - 11:19am
tags:
Sanofi, Pfizer, Ironwood Pharmaceuticals, FDA
Allergan Stock To Go Ex-dividend Tomorrow
TheStreet.com
Monday, August 20, 2012 - 11:18am
tags:
Allergan
Aetna To Buy Coventry For $5.6 Billion To Add Medicare Plans
Bloomberg
Monday, August 20, 2012 - 10:57am
tags:
Coventry Healthcare, Aetna, M&A, Medicare
Dendreon's Provenge: Early Stage Use
Seeking Alpha
Monday, August 20, 2012 - 10:51am
tags:
Provenge, prostate cancer, Dendreon, JNJ
New coupons aim to keep people off generic drugs
Yahoo/AP
Monday, August 20, 2012 - 10:49am
tags:
generics, drug coupons, Pfizer, Lipitor, Plavix, Bristol-Myers Squibb
Novartis, A Gleevec Patent & India: Herrling Explains
Pharmalot
Monday, August 20, 2012 - 10:39am
tags:
India, Novartis, Gleevec
ARIAD Begins Phase 1/2 Trial of Ponatinib in Japan
Yahoo
Monday, August 20, 2012 - 10:33am
tags:
Ariad Pharmaceuticals, Japan, Ponatinib
8 Intriguing Small Cap Biotechnology Companies For Your Consideration
Seeking Alpha
Monday, August 20, 2012 - 10:32am
tags:
Affymax, Alnylam, Arena Pharmaceuticals, Aveo, BioTime, ChemoCentryx, Emergent BioSolutions, Clovis Oncology, Enzon, Forest Labs, Geron, ViroPharma, Targacept, GSK, Pfizer, Santarus, PDL Biopharma, Infinity Pharmaceuticals, Nektar
Celgene may purchase $4.9M in additional shares of Globelmmune
The Fly on the Wall
Monday, August 20, 2012 - 10:28am
tags:
Celgene, GlobeImmune, M&A

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.